ARF_180_2: IRB - Counterparty Credit Risk and CVA Risk
|
|
|
|
|
|
|
|
Effective date: 20 February 2020
|
|
|
|
Australian Business Number
|
Institution Name
|
|
|
|
|
Reporting Period
|
Scale Factor
|
|
|
Millions to one decimal place
|
|
Reporting Consolidation
|
|
|
Level 1 / Level 2
|
|
|
|
|
Section A: IRB bilateral exposures
|
|
|
|
1. Derivative exposures - AIRB or FIRB
|
|
|
|
PD %
|
Number of counterparties
|
Notional principal amount
|
Replacement cost excluding all collateral
|
Replacement cost with eligible collateral
|
Scaled IR AddOn
|
Scaled FX AddOn
|
Scaled CR AddOn
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
|
|
|
|
|
|
|
|
|
|
|
PD %
|
Scaled EQ AddOn
|
Scaled CMDTY AddOn
|
Potential future exposure
|
EAD
|
Incurred CVA loss
|
Weighted average LGD
|
Weighted average maturity
|
RWE
|
(1)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
(15)
|
(16)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.1. Total RWE
|
|
|
|
|
|
|
|
|
|
|
2. Securities financing transactions - AIRB or FIRB
|
|
|
|
PD %
|
Number of counterparties
|
Notional principal amount
|
Adjusted exposure amount
|
Weighted average LGD
|
Weighted average maturity
|
RWE
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2.1. Total RWE
|
|
|
|
|
|
|
|
|
|
3. Derivative exposures - supervisory slotting
|
|
|
|
Slotting category
|
Number of counterparties
|
Notional principal amount
|
Replacement cost excluding all collateral
|
Replacement cost with eligible collateral
|
Scaled IR AddOn
|
Scaled FX AddOn
|
Scaled CR AddOn
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
|
|
|
|
|
|
|
|
|
Strong
|
|
|
|
|
|
|
|
|
Good
|
|
|
|
|
|
|
|
|
Satisfactory
|
|
|
|
|
|
|
|
|
Weak
|
|
|
|
|
|
|
|
|
Default
|
|
|
|
|
|
|
|
|
|
|
Slotting category
|
Scaled EQ AddOn
|
Scaled CMDTY AddOn
|
Potential future exposure
|
EAD
|
Incurred CVA loss
|
RWE
|
|
(1)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
|
|
|
|
|
|
|
|
|
|
Strong
|
|
|
|
|
|
|
|
Good
|
|
|
|
|
|
|
|
Satisfactory
|
|
|
|
|
|
|
|
Weak
|
|
|
|
|
|
|
|
Default
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3.1. Total RWE
|
|
|
|
|
|
|
|
|
|
4. Securities financing transactions - supervisory slotting
|
|
|
|
Slotting category
|
Number of counterparties
|
Notional principal amount
|
Adjusted exposure amount
|
RWE
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
|
|
|
|
|
|
|
|
|
|
Strong
|
|
|
|
|
|
Good
|
|
|
|
|
|
Satisfactory
|
|
|
|
|
|
Weak
|
|
|
|
|
|
Default
|
|
|
|
|
|
|
|
|
|
|
|
4.1. Total RWE
|
|
|
|
|
|
|
|
Section B: Other IRB and non-IRB bilateral exposures
|
|
|
|
5. Derivative exposures
|
|
|
|
Exposure type
|
Number of counterparties
|
Notional principal amount
|
Replacement cost excluding all collateral
|
Replacement cost with eligible collateral
|
Scaled IR AddOn
|
Scaled FX AddOn
|
Scaled CR AddOn
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
(7)
|
(8)
|
|
|
|
|
|
|
|
|
|
|
Other IRB
|
|
|
|
|
|
|
|
|
Non-IRB
|
|
|
|
|
|
|
|
|
|
|
Exposure type
|
Scaled EQ AddOn
|
Scaled CMDTY AddOn
|
Potential future exposure
|
EAD
|
Incurred CVA loss
|
RWE
|
|
(1)
|
(9)
|
(10)
|
(11)
|
(12)
|
(13)
|
(14)
|
|
|
|
|
|
|
|
|
|
|
Other IRB
|
|
|
|
|
|
|
|
Non-IRB
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5.1. Total RWE
|
|
|
|
|
|
|
|
|
|
6. Securities financing transactions
|
|
|
|
Exposure type
|
Number of counterparties
|
Notional principal amount
|
Adjusted exposure amount
|
RWE
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
|
|
|
|
|
|
|
|
|
|
Other IRB
|
|
|
|
|
|
Non-IRB
|
|
|
|
|
|
|
|
|
|
|
|
6.1. Total RWE
|
|
|
|
|
|
|
|
Section C: Exposures to central counterparties
|
|
|
|
7. Derivative exposures
|
|
|
|
Name of central counterparty
|
Risk weight
|
Notional principal amount
|
Trade exposure
|
RWE
|
Total collateral posted
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7.1. Other central counterparties
|
|
|
|
Risk weight
|
Notional principal amount
|
Trade exposure
|
RWE
|
Total collateral posted
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
0.02
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
7.2. Total RWE for centrally cleared derivatives
|
|
|
|
|
|
7.2.1. As a clearing member ADI: exposures eligible for a 0% risk
weight
|
|
|
|
|
|
7.2.2. As a clearing member ADI: exposures eligible for a 2% risk
weight
|
|
|
|
|
|
7.2.3. As a clearing member ADI: exposures eligible for a 4% risk
weight
|
|
|
|
|
|
|
|
8. Securities financing transactions
|
|
|
|
Name of central counterparty
|
Risk weight
|
Notional principal amount
|
Trade exposure
|
RWE
|
Total collateral posted
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
|
0.02
|
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
8.1. Other central counterparties
|
|
|
|
Risk weight
|
Notional principal amount
|
Trade exposure
|
RWE
|
Total collateral posted
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
|
|
|
|
|
|
|
|
|
|
0
|
|
|
|
|
|
0.02
|
|
|
|
|
|
0.04
|
|
|
|
|
|
|
|
|
|
|
|
8.2. Total RWE for centrally cleared SFTs
|
|
|
|
|
|
|
|
9. Default fund contribution to a qualifying central counterparty
|
|
|
|
Name of central counterparty
|
K_QCCP
|
DF_ADI
|
DF_CM
|
DF_CCP
|
K_ADI
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9.1. Other qualifying central counterparties
|
|
|
|
|
|
|
9.2. Total QCCP default fund capital charge
|
|
|
|
|
|
|
|
|
10. Trade exposure RWE and default fund contribution to a
non-qualifying central counterparty
|
|
|
|
Name of central counterparty
|
Trade exposure
|
Trade exposure RWE
|
Prefunded default fund contribution
|
Unfunded default fund contribution
|
Default fund RWE
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10.1. Other qualifying central counterparties
|
|
|
|
|
|
|
10.2. Total
|
|
|
|
|
|
|
|
|
Section D: CVA risk capital charge
|
|
|
|
11. CVA risk capital charge
|
|
|
|
|
Rating grade weighting
|
CVA capital formula component 1
|
CVA capital formula component 2
|
CVA capital formula component 3
|
Derived quantity 1
|
Derived quantity 2
|
|
|
(1)
|
(2)
|
(3)
|
(4)
|
(5)
|
(6)
|
|
|
11.1. CVA capital charge components, credit rating grade = 1
|
|
|
|
|
|
|
|
11.2. CVA capital charge components, credit rating grade = 2
|
|
|
|
|
|
|
|
11.3. CVA capital charge components, credit rating grade = 3
|
|
|
|
|
|
|
|
11.4. CVA capital charge components, credit rating grade = 4 or
unrated
|
|
|
|
|
|
|
|
11.5. CVA capital charge components, credit rating grade = 5
|
|
|
|
|
|
|
|
11.6. CVA capital charge components, credit rating grade = 6
|
|
|
|
|
|
|
|
11.7. Total CVA capital charge components
|
|
|
|
|
|
|
|
11.8. Total CVA capital charge
|
|
|
|
|
|
|
|
|
|
Section E: Summary
|
|
|
|
12. Market related off-balance sheet exposures
|
|
|
|
12.1. Bilateral exposures - IRB default risk RWE (including
supervisory slotting)
|
|
|
12.2. Bilateral exposures - Other IRB and Non-IRB default risk RWE
|
|
|
12.3. CCP trade exposure RWE
|
|
|
12.4. CCP default fund RWE
|
|
|
12.5. CVA RWE
|
|
|
|
|
13. Securities financing transaction exposures
|
|
|
|
13.1. Total SFT trade exposure RWE
|
|
|
13.1.1. Bilateral SFT - IRB RWE (including supervisory slotting)
|
|
|
13.1.2. Bilateral SFT - Other IRB and Non-IRB RWE
|
|
|
13.1.3. Centrally cleared SFT RWE
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|